vimarsana.com
Home
Live Updates
Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy : comparemela.com
Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy
/PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy,...
Related Keywords
Norway ,
Oslo ,
United States ,
Switzerland ,
Norwegian ,
Mortene Iversen ,
Federico Grego ,
Christer Kjos ,
Lars Prestegarden ,
Frazer Hall Mark ,
Merck Co Inc ,
University Of Bergen Norway ,
Merck Sharp Dohme Corp ,
Merck Sharp ,
Dohme Corp ,
Chief Business Officer ,
Mark Swallow ,
George Underwood ,
Cytovation As ,
comparemela.com © 2020. All Rights Reserved.